# Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/utility-of-a-third-heplisav-b-dose-in-patients-with-inflammatory-bowel-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christian Karime,Cecily N. Black,Pedro Cortés,Joshua Kwon,Freddy Caldera,Sheena Crosby,Michael F. Picco,Jami Kinnucan,Jana G. Hashash,Francis A. Farraye |
| Citations | 9 |
| DOI | 10.14309/ajg.0000000000002863 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4396735793 |
| PMID | 38717045 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Christian Karime](https://scholariq.org/researchers/christian-karime/)

## Paper journal

- [The American Journal of Gastroenterology](https://scholariq.org/journals/the-american-journal-of-gastroenterology/)

## Paper primary topic

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)

## Paper topics

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.